Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 16895577)

Published in J Neurochem on August 01, 2006

Authors

Andreas Meisel1, Christoph Harms, Ferah Yildirim, Julian Bösel, Golo Kronenberg, Ulrike Harms, Klaus B Fink, Matthias Endres

Author Affiliations

1: Klinik und Poliklinik für Neurologie, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.

Articles citing this

Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging (2011) 3.83

Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98

Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95

Epigenetics in the nervous system. J Neurosci (2008) 1.65

Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection. J Neurosci (2008) 1.61

Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. J Neurochem (2009) 1.28

Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs (2009) 1.28

Protective conditioning of the brain: expressway or roadblock? J Physiol (2011) 1.05

Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.93

Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des (2013) 0.93

Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology (Berl) (2011) 0.90

A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Am J Physiol Renal Physiol (2013) 0.90

Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury. PLoS One (2014) 0.89

Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia. J Cereb Blood Flow Metab (2010) 0.88

Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions. CNS Neurosci Ther (2010) 0.87

Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia. J Cereb Blood Flow Metab (2015) 0.78

Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1. Mol Cell Neurosci (2013) 0.78

Epigenetic Regulation of Oxidative Stress in Ischemic Stroke. Aging Dis (2016) 0.77

Articles by these authors

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Milestones of neuronal development in the adult hippocampus. Trends Neurosci (2004) 5.80

Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med (2014) 5.79

Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development (2003) 4.49

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18

Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology (2012) 2.60

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation (2003) 2.59

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol (2002) 2.54

Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci (2003) 2.33

Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res (2006) 2.21

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke (2007) 2.13

Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. Stroke (2013) 2.11

Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Stroke (2013) 2.07

Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology (2013) 2.04

Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? Stroke (2009) 1.99

Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes. Mol Cell Neurosci (2003) 1.94

Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med (2008) 1.91

Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation. BMC Neurosci (2006) 1.84

Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75

Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol (2008) 1.68

Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice. Glia (2004) 1.67

Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol Psychiatry (2006) 1.66

Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci (2005) 1.65

Treatment Options for Statin-Associated Muscle Symptoms. Dtsch Arztebl Int (2015) 1.55

3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol (2012) 1.52

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med (2003) 1.47

Roller culture of free-floating retinal slices: a new system of organotypic cultures of adult rat retina. Ophthalmic Res (2006) 1.42

Left atrial catheter ablation and ischemic stroke. Stroke (2011) 1.39

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res (2002) 1.36

Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med (2012) 1.34

Age-dependent expression of glucocorticoid- and mineralocorticoid receptors on neural precursor cell populations in the adult murine hippocampus. Aging Cell (2004) 1.34

Depressed new neurons--adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry (2003) 1.34

SUMO2/3 conjugation is an endogenous neuroprotective mechanism. J Cereb Blood Flow Metab (2011) 1.32

A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke (2013) 1.29

Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A (2013) 1.28

Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke (2012) 1.24

Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. J Clin Invest (2004) 1.22

Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol (2007) 1.21

Stroke and myocardial infarction: a comparative systematic evaluation of gender-specific analysis, funding and authorship patterns in cardiovascular research. Cerebrovasc Dis (2011) 1.20

Properties of doublecortin-(DCX)-expressing cells in the piriform cortex compared to the neurogenic dentate gyrus of adult mice. PLoS One (2011) 1.17

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem (2005) 1.17

Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am J Physiol Heart Circ Physiol (2002) 1.15

Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One (2011) 1.14

Withdrawal of statin treatment abrogates stroke protection in mice. Stroke (2003) 1.13

Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci (2007) 1.12

Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci (2008) 1.10

Essential role of interleukin-6 in post-stroke angiogenesis. Brain (2012) 1.09

Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med (2009) 1.09

Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study. BMC Neurol (2009) 1.08

The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia (2008) 1.08

Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol Cell Neurosci (2004) 1.07

A new role for nortriptyline in depression associated with vascular disease? Am J Psychiatry (2015) 1.07

Benefit and accuracy of intraoperative 3D-imaging after pedicle screw placement: a prospective study in stabilizing thoracolumbar fractures. Eur Spine J (2009) 1.05

Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke (2007) 1.05

Chronic heart failure and ischemic stroke. Stroke (2011) 1.04

Modulation of fate determinants Olig2 and Pax6 in resident glia evokes spiking neuroblasts in a model of mild brain ischemia. Stroke (2010) 1.04

Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis. Stroke (2011) 1.03

Effects of the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res (2009) 1.03

Identifying the perfusion deficit in acute stroke with resting-state functional magnetic resonance imaging. Ann Neurol (2013) 1.03

Hippocampal volume reduction and HPA-system activity in major depression. J Psychiatr Res (2006) 1.02

Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods (2013) 1.01

Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke (2009) 1.01

DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke (2011) 1.01

HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J Neurochem (2004) 1.01

Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Crit Care (2010) 1.00

The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol (2012) 1.00

A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Res (2006) 0.99

Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J Neurosci (2011) 0.99

Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis. J Neurosci (2010) 0.99

Ischemic injury in experimental stroke depends on angiotensin II. FASEB J (2002) 0.99

In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke (2008) 0.99